Bright Eye Hospital Group Co., Ltd. (SHE:301239)
China · Delayed Price · Currency is CNY 34.41
-0.25 (-0.72%)
Oct 29, 2026, 4:00 PM EDT
Bright Eye Hospital Group Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 472.18 | 339.71 | 481.07 | 806.6 | 926.23 | 170.77 |
Trading Asset Securities | 80.74 | 90.72 | 20.09 | 30.1 | - | - |
Cash & Short-Term Investments | 552.91 | 430.43 | 501.16 | 836.7 | 926.23 | 170.77 |
Cash Growth | 23.85% | -14.11% | -40.10% | -9.67% | 442.37% | -40.10% |
Accounts Receivable | 85.23 | 99.29 | 101.7 | 119.29 | 58.14 | 54.3 |
Other Receivables | 76.19 | 91.92 | 88.26 | 77.12 | 67.94 | 70.58 |
Receivables | 161.42 | 191.22 | 189.96 | 196.41 | 126.09 | 124.88 |
Inventory | 228.36 | 202.64 | 148.31 | 151.53 | 107.62 | 90.05 |
Prepaid Expenses | - | - | - | - | 15.79 | 6.13 |
Other Current Assets | 76.88 | 33.6 | 29.82 | 30.17 | 11.97 | 27.67 |
Total Current Assets | 1,020 | 857.88 | 869.26 | 1,215 | 1,188 | 419.5 |
Property, Plant & Equipment | 2,491 | 2,503 | 2,569 | 2,590 | 1,474 | 1,472 |
Long-Term Investments | 176.24 | 167.18 | 170.09 | 103.77 | 267.43 | 168.88 |
Goodwill | 565.87 | 411.9 | 407.58 | 392 | 27.38 | 29.03 |
Other Intangible Assets | 41.01 | 42.45 | 46.73 | 50.98 | 10.48 | 12.44 |
Long-Term Deferred Tax Assets | 18.13 | 16.82 | 20.73 | 15.67 | 12.82 | 8.25 |
Long-Term Deferred Charges | 412.53 | 440.5 | 487.6 | 420.75 | 388.74 | 204.79 |
Other Long-Term Assets | 21.7 | 116.1 | 27.29 | 27.36 | 308.46 | 11.06 |
Total Assets | 4,746 | 4,556 | 4,598 | 4,815 | 3,677 | 2,326 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 307.65 | 305.64 | 321.07 | 417.55 | 190.42 | 147.08 |
Accrued Expenses | 142.57 | 187.33 | 180.39 | 144.14 | 92.94 | 81.13 |
Short-Term Debt | 116.91 | 96.38 | 158.99 | 233.06 | 102.64 | 110.14 |
Current Portion of Long-Term Debt | 333.65 | 52.06 | 33.11 | 12.65 | 8.13 | - |
Current Portion of Leases | - | 168.59 | 156.05 | 162.2 | 137.2 | 98.82 |
Current Income Taxes Payable | 47.45 | 26.6 | 24.77 | 51.83 | 29.02 | 29.49 |
Current Unearned Revenue | 25.29 | 21.96 | 16.99 | 15.95 | 18.64 | 19.48 |
Other Current Liabilities | 63.25 | 7.59 | 7.72 | 5.74 | 3.35 | 3.48 |
Total Current Liabilities | 1,037 | 866.13 | 899.09 | 1,043 | 582.33 | 489.63 |
Long-Term Debt | 326.07 | 387.58 | 345.37 | 94.81 | 88.5 | - |
Long-Term Leases | 1,200 | 1,232 | 1,230 | 1,356 | 936.48 | 885.24 |
Long-Term Unearned Revenue | 0.27 | 0.24 | 0.24 | - | - | - |
Long-Term Deferred Tax Liabilities | 3 | 3 | 2.45 | 2.89 | 2.13 | 2.45 |
Total Liabilities | 2,566 | 2,489 | 2,477 | 2,497 | 1,609 | 1,377 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 149.62 | 149.62 | 149.62 | 149.62 | 149.62 | 112.21 |
Additional Paid-In Capital | 1,738 | 1,738 | 1,736 | 1,735 | 1,734 | 672.68 |
Retained Earnings | 321 | 214.6 | 275.52 | 436.93 | 183.98 | 163.41 |
Treasury Stock | -59.77 | -59.77 | -59.77 | -29.98 | - | - |
Comprehensive Income & Other | -0.11 | -0.11 | -0.14 | -0.29 | -0.28 | -0 |
Total Common Equity | 2,148 | 2,042 | 2,101 | 2,292 | 2,068 | 948.3 |
Minority Interest | 31.62 | 25.02 | 19.67 | 26.59 | - | - |
Shareholders' Equity | 2,180 | 2,067 | 2,121 | 2,318 | 2,068 | 948.3 |
Total Liabilities & Equity | 4,746 | 4,556 | 4,598 | 4,815 | 3,677 | 2,326 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 1,977 | 1,936 | 1,923 | 1,859 | 1,273 | 1,094 |
Net Cash (Debt) | -1,424 | -1,506 | -1,422 | -1,022 | -346.72 | -923.42 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -9.46 | -10.14 | -9.49 | -6.83 | -2.70 | -8.26 |
Filing Date Shares Outstanding | 150.02 | 148.86 | 148.86 | 148.86 | 149.62 | 112.21 |
Total Common Shares Outstanding | 150.02 | 148.86 | 148.86 | 149.31 | 149.62 | 112.21 |
Working Capital | -17.2 | -8.25 | -29.83 | 171.67 | 605.37 | -70.13 |
Book Value Per Share | 14.32 | 13.72 | 14.12 | 15.35 | 13.82 | 8.45 |
Tangible Book Value | 1,541 | 1,588 | 1,647 | 1,849 | 2,030 | 906.83 |
Tangible Book Value Per Share | 10.27 | 10.66 | 11.07 | 12.38 | 13.57 | 8.08 |
Buildings | - | - | - | 470.26 | 43.63 | 43.63 |
Machinery | - | 1,181 | 1,035 | 802.98 | 656.09 | 556.36 |
Construction In Progress | - | 12.8 | 53.14 | 276.36 | 62.51 | 145.21 |